G. Krikorian

access to knowledge in the age of intellectual property

G. Krikorian, A. Kapczynski, 2010 .

We Cannot Win the Access to Medicines Struggle Using the Same Thinking That Causes the Chronic Access Crisis

G. Krikorian, E. Torreele, 2021, Health and human rights.

From AIDS to Free Trade Agreements: Knowledge Activism in Thailand’s Movement for Access to Medicines

G. Krikorian, 2017 .

Supplementary protection certificates and their impact on access to medicines in Europe: case studies of sofosbuvir, trastuzumab and imatinib

G. Krikorian, P. Boulet, Yuanqiong Hu, 2020, Journal of pharmaceutical policy and practice.

Supplementary protection certificates and their impact on access to medicines in Europe: case studies of sofosbuvir, trastuzumab and imatinib

G. Krikorian, P. Boulet, Yuanqiong Hu, 2020, Journal of Pharmaceutical Policy and Practice.

Rationing hepatitis C treatment in the context of austerity policies in France and Cameroon: A transnational perspective on the pharmaceuticalization of healthcare systems.

G. Krikorian, P. David, F. Chabrol, 2017, Social science & medicine.

Intellectual Property Rights in the Making: The Evolution of Intellectual Property Provisions in US Free Trade Agreements and Access to Medicine

G. Krikorian, Dorota Szymkowiak, 2007 .

New Antiretroviral Treatments and Post-2005 TRIPS Constraints: First Moves Towards IP Flexibilization in Developing Countries

B. Coriat, G. Krikorian, L. Hasenclever, 2008 .